History
  • No items yet
midpage
746 F.3d 157
5th Cir.
2014
Read the full case

Background

  • Relators filed a qui tam FCA action against their former employers for allegedly fraudulent Medicare/Medicaid claims.
  • Governmentcriminally prosecuted the Sharmas, resulting in restitution/forfeiture orders; initial restitution was affirmed and later recalculated on appeal.
  • Relators filed the FCA action Nov 17, 2011, while the criminal appeal was pending; Government declined to intervene in the qui tam action.
  • District court granted partial summary judgment: no alternate remedy under 31 U.S.C. § 3730(c)(5) because no qui tam action was pending when restitution commenced.
  • Relators sought discovery to determine their share; appellate interlocutory review granted; June 2013 resentencing in criminal case increased restitution, which is under appeal.
  • This appeal evaluates whether restitution qualifies as an “alternate remedy” to the qui tam action under § 3730(c)(5).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether restitution constitutes an alternate remedy under § 3730(c)(5). Babalola argues the criminal restitution was an alternate remedy since a qui tam action was not pending. Sharmas argue no alternate remedy existed because no qui tam action was pending at the start of restitution. No; restitution did not constitute an alternate remedy.
Whether a pending qui tam action is required to trigger § 3730(c)(5). Relators contend the statute protects their rights whenever the government pursues an alternate remedy. Defendants contend a quo tam must be filed and pending for an alternate remedy to apply. Yes; a qui tam proceeding must be in existence at the time of the government’s election of the alternate remedy.
What does “same rights” in § 3730(c)(5) mean in the race-to-the-courthouse context? Relators should retain bounty rights if the government pursues an alternate remedy after their disclosure. If the government pursues an alternate remedy first, relators get no bounty. Relators retain the same rights as if the qui tam had continued; otherwise the bounty would be forfeited in such race scenarios.
Does § 3730(e)(3) reinforce the race-to-the-courthouse risk for relators? Relators rely on 3730(e)(3) to preserve their ability to pursue a qui tam when the government delays or avoids intervention. Court relies on § 3730(e)(3) to prevent duplicative actions when the government pursues a civil action first; relators may be barred if no qui tam is filed first.

Key Cases Cited

  • LaCorte v. Wagner, 185 F.3d 188 (4th Cir. 1999) (alternate remedy rights preserved when government pursues an alternate remedy)
  • Barajas v. Northrop Corp., 258 F.3d 1004 (9th Cir. 2001) (alternate remedy described as government pursuit after non-intervention)
  • Reagan v. East Tex. Med. Ctr. Reg’l Healthcare Sys., 384 F.3d 168 (5th Cir. 2004) (disclosure and qui tam timing under FCA procedures)
  • Rockwell Intern. Corp. v. United States, 549 U.S. 457 (2007) (qui tam meaning and public policy context)
Read the full case

Case Details

Case Name: Samuel Babalola v. Arun Sharma
Court Name: Court of Appeals for the Fifth Circuit
Date Published: Feb 17, 2014
Citations: 746 F.3d 157; 13-20182
Docket Number: 13-20182
Court Abbreviation: 5th Cir.
Log In
    Samuel Babalola v. Arun Sharma, 746 F.3d 157